Lines to Be Made Available Free-of-Charge for Research
A research team led by UC Irvine neurobiologist Hans Keirstead will generate up to five new human embryonic stem cell lines to be used for research into treatments for spinal cord injury, diabetes and Parkinson's disease. The lines will be the first developed at UCI.
Keirstead, co-director of UCI's Stem Cell Research Center, and Gabriel Nistor, a scientist in his laboratory, will derive the new lines from surplus embryos donated by couples undergoing fertility treatment at West Coast Fertility Centers in Orange County. Embryo donations will be made with the informed consent of donor couples and under a procedure approved by UCI's Embryonic Stem Cell Research Oversight Committee. Once the lines have been created and tested in labs at UCI, Keirstead plans to make them available to researchers worldwide free of charge.
"Generating new stem cell lines is an essential next step in the progression of stem cell research toward the development of new research tools and treatments for human disease," said Keirstead, associate professor of anatomy and neurobiology. "We are committed to making these lines available to the scientific community so that other researchers may join us in our pursuit of better therapies for devastating diseases."
Keirstead will work with Dr. David Diaz, West Coast Fertility Centers' medical director, to use novel techniques for developing the new lines, as well as freezing and preserving the lines after they have been created. The techniques for freezing and preserving lines were developed at the clinic for the preservation of embryos.
Stem cells are the "master" cells that give rise to each of the specialized cells within the human body. During organ and tissue development, these cells transform into a particular specialized cell, such as a heart cell or a liver cell, when prompted by their environment or by their internal genetic programming. If researchers can control the processes directing stem cell transformation, they may one day be able to use these cells as a source of healthy replacement cells for tissues damaged by disease or injury. This work has been the subject of Keirstead's recent research.
New embryonic stem cell lines are derived from three- to five-day-old embryos produced during fertilization treatments. The excess embryos are often frozen indefinitely or discarded as medical waste. Donors must give permission before these embryos can be used for research purposes.
Keirstead will make lines not only from healthy embryos, but also from embryos known to harbor genetic abnormalities. Stem cells derived from these lines can be used as cellular models of human disease that may help scientists better understand these genetic diseases.
Funding for the development of new lines at UCI will come from private sources. Since 2001, the U.S. government limits funding for stem cell research to lines that were already in existence before that date.
Keirstead is one of the nation's pioneers in the use of human embryonic stem cells in the study of spinal cord injuries. In 2005, he used a treatment derived from human embryonic stem cells to improve mobility in rats with spinal cord injuries. He plans to use any new stem cell lines he develops for further research in spinal cord injury and disease in his laboratory.
The creation of new stem cell lines represents another step in UCI's development as one of the premier centers for stem cell research in California. The university plans to construct a $60 million Stem Cell Research Institute facility aimed at propelling stem cell technology from the research lab to the clinic.
About the University of California, Irvine: The University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 24,000 undergraduate and graduate students and about 1,400 faculty members. The second-largest employer in dynamic Orange County, UCI contributes an annual economic impact of $3.3 billion. For more UCI news, visit www.today.uci.edu.
Television: UCI has a broadcast studio available for live or taped interviews. For more information, visit www.today.uci.edu/broadcast.
News Radio: UCI maintains on campus an ISDN line for conducting interviews with its faculty and experts. The use of this line is available free-of-charge to radio news programs/stations who wish to interview UCI faculty and experts. Use of the ISDN line is subject to availability and approval by the university.